Click Here!Click Here!
Home / Health / FDA launches foe to coax innovative technologies to assistance revoke opioid overdose deaths
FDA launches foe to coax innovative technologies to assistance revoke opioid overdose deaths

FDA launches foe to coax innovative technologies to assistance revoke opioid overdose deaths

Español

The U.S. Food and Drug Administration now announced a 2016 Naloxone App Competition, a open foe focused on building innovative technologies to fight a rising widespread of opioid overdose.
 
The FDA, with support from a National Institute on Drug Abuse (NIDA) and a Substance Abuse and Mental Health Services Administration (SAMHSA), is mouth-watering mechanism programmers, open health advocates, clinical researchers, entrepreneurs and innovators from all disciplines to emanate a mobile phone focus that can bond opioid users experiencing an overdose with circuitously carriers of a remedy drug naloxone – a remedy for an opioid overdose – thereby augmenting a odds of timely administration and overdose reversal.

This foe builds on work announced in a FDA’s Opioids Action Plan and a U.S. Department of Health and Human Services’ Opioid Initiative (PDF – 350KB) to take petrify stairs toward shortening a impact of opioid misuse, coherence and overdose on American families and communities by creation naloxone some-more accessible.

“With a thespian boost in a series of opioid overdose deaths in a U.S., there’s a critical need to strap a energy of new technologies to fast and effectively couple people experiencing an overdose – or a bystander such as a crony or family member – with someone who carries and can discharge a life-saving medication,” pronounced FDA Commissioner Robert M. Califf, M.D. “Through this competition, we are drumming open health-focused innovators to assistance move technological solutions to a real-world problem that is costing a U.S. thousands of lives any year.”

According to SAMHSA, scarcely dual million Americans abused or were contingent on remedy opioids in 2014. Additionally, overdose deaths involving remedy opioids such as oxycodone, hydrocodone and hypnotic and unlawful opioids, such as heroin and illegally constructed fentanyl, have some-more than tripled given 1999 – with about 28,000 people failing in 2014 alone. Many of these deaths could have been avoided if people experiencing an overdose had immediately perceived naloxone to stop or retreat a effects of an opioid overdose.

Naloxone is now usually permitted in a U.S. by prescription, though many states have taken stairs to make it some-more straightforwardly permitted to initial responders, community-based organizations and laypersons, including friends and family of opioid users. In fact, a series of laypersons supposing naloxone scarcely tripled between 2010 and 2014, according to a U.S. Centers for Disease Control and Prevention. However, persons carrying naloxone might not be benefaction when an overdose occurs.

“The idea of this foe is to rise a low-cost, scalable, crowd-sourced mobile focus that addresses this emanate of accessibility,” pronounced Peter Lurie, M.D., M.P.H., associate commissioner for open health plan and research during a FDA. “Mobile phone applications have been grown to teach laypersons on how to commend an overdose and discharge naloxone, and to bond bystanders with people in need of other medical services, such as CPR. To date, however, no focus is permitted to bond carriers of naloxone with circuitously opioid overdose victims.”

Teams and people wishing to attend in a foe will have until Oct. 7, 2016 to register. Registrants will have entrance to credentials resources, including information on a opioid epidemic, a authorized formulations of naloxone, a open health recommendations for a protected and suitable use of naloxone and FDA superintendence on mobile medical applications. On Oct. 19-20, 2016, a FDA will horde a two-day code-a-thon on a FDA campus and probably for purebred entrants to rise their concepts and initial prototypes. All formula will be done open-source and publicly accessible, and partnership will be encouraged. Competition participants will afterwards exclusively labour their judgment and contention a video of a organic antecedent along with a brief outline of their judgment for a growth and use of a app by Nov. 7, 2016.

A row of judges from a FDA, NIDA, and SAMHSA will weigh submissions and a highest-scoring entrant will accept an endowment of $40,000. Following a competition, entrants also might request for NIDA Small Business Innovation Research (SBIR) grants, theme to eligibility mandate set onward in a SBIR appropriation event announcement, to serve rise their concepts and to rise information to weigh their real-world impact.

The Naloxone App Competition was grown underneath a America Creating Opportunities to Meaningfully Promote Excellence in Technology, Education, and Science (COMPETES) Reauthorization Act of 2010, that grants all sovereign agencies extended management to control esteem competitions to coax innovation, solve tough problems and allege their core missions.

Follow a Naloxone App Competition on amicable media controlling #NaloxoneApp.

The FDA, an group within a U.S. Department of Health and Human Services, protects a open health by assuring a safety, effectiveness, and confidence of tellurian and veterinary drugs, vaccines and other biological products for tellurian use, and medical devices. The group also is obliged for a reserve and confidence of the nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for controlling tobacco products.

###

About admin

Scroll To Top